If the above hypothesis, which is not completely improbable, were true - why go with the placement with GF for Stage 3 expansion funding? They got a very good deal on the placement. As others have stated, perhaps that was the trade-off for renegotiation of the pricing formula? Given the pricing formula was never disclosed (and labelled confidential), renegotiation of it would not theoretically trigger a market sensitive announcement. In addition, the short selling is not specific to PLS, but a sector wide phenomenon. They are clearly betting on the macro rather than the micro.
Dial in details 25.1.19 Quarterly, page-77
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.70 |
Change
0.340(14.4%) |
Mkt cap ! $8.220B | |||
| Open | High | Low | Value | Volume |
| $2.55 | $2.77 | $2.53 | $97.24M | 36.73M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 91794 | $2.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.70 | 144977 | 28 |
View Market Depth
| Last trade - 12.32pm 11/09/2024 (20 minute delay) ? |
| PLS (ASX) Chart |